Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside

Zixian Xie1, Yumin Luo2,3, Ziping Han4

  • 1Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.

PubMed

Insights

Enhancing DNA repair offers a promising strategy to reduce brain damage and improve recovery after ischemic stroke. This review explores therapeutic approaches targeting DNA damage response pathways for neuroprotection.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Neurology

Background:

  • Cerebral ischemic stroke treatment remains challenging despite reperfusion therapies.
  • DNA damage and the DNA damage response (DDR) are increasingly recognized in stroke pathophysiology.
  • Inflammatory and apoptotic pathways are key downstream mediators in stroke.

Purpose of the Study:

  • To review recent neuroprotective strategies modulating DNA damage and repair pathways in stroke.
  • To focus on therapeutic interventions for both clinical ischemic stroke patients and experimental models.
  • To explore future directions in DNA repair-based stroke therapies.

Main Methods:

  • Literature review of studies on DNA damage, repair, and neuroprotection in stroke.
  • Analysis of research focusing on modulating the DNA damage response (DDR) pathways.
  • Inclusion of findings from both human clinical studies and experimental stroke models.

Main Results:

  • Evidence highlights the critical role of DNA damage in stroke-induced neural injury.
  • Modulating DNA repair pathways shows potential for mitigating stroke damage.
  • Targeting DDR offers a promising therapeutic avenue for neuroprotection and functional recovery.

Conclusions:

  • Enhancing DNA repair represents a viable therapeutic strategy for ischemic stroke.
  • Further research into DDR modulation could lead to improved stroke outcomes.
  • Future studies should explore novel approaches to harness DNA repair mechanisms for neuroprotection.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...